Title | Exploration of Targeted Anti-tumor Therapy |
Abbreviation | Explor. Target. Anti-tumor Ther. |
Publication Type | Journal |
Subject Area, Categories, Scope | Oncology (Q2); Cancer Research (Q3) |
h-index | 10 |
Overall Rank/Ranking | 7575 |
SCImago Journal Rank (SJR) | 0.692 |
Impact Score | 2.12 |
Publisher | Open Exploration Publishing Inc |
Country | China |
ISSN | 26923114 |
Best Quartile | Q2 |
Coverage History | 2020-2023 |
Exploration of Targeted Anti-tumor Therapy is a journal covering the technologies/fields/categories related to Oncology (Q2); Cancer Research (Q3). It is published by Open Exploration Publishing Inc. The overall rank of Exploration of Targeted Anti-tumor Therapy is 7575. According to SCImago Journal Rank (SJR), this journal is ranked 0.692. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 10. The best quartile for this journal is Q2.
The ISSN of Exploration of Targeted Anti-tumor Therapy journal is 26923114. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Exploration of Targeted Anti-tumor Therapy is cited by a total of 325 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Exploration of Targeted Anti-tumor Therapy is 2.12, which is computed in 2024 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Exploration of Targeted Anti-tumor Therapy is 2.12. If the same upward trend persists, Impact IF may rise in 2024 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2023 | 2.12 |
Exploration of Targeted Anti-tumor Therapy has an h-index of 10. It means 10 articles of this journal have more than 10 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Exploration of Targeted Anti-tumor Therapy is 26923114. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Exploration of Targeted Anti-tumor Therapy is 7575. According to SCImago Journal Rank (SJR), this journal is ranked 0.692. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2023 | 0.692 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2023 | 7575 |
Exploration of Targeted Anti-tumor Therapy is published by Open Exploration Publishing Inc. It's publishing house is located in China. Coverage history of this journal is as following: 2020-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Exploration of Targeted Anti-tumor Therapy is Explor. Target. Anti-tumor Ther.. This abbreviation ('Explor. Target. Anti-tumor Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q2); Cancer Research (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Exploration of Targeted Anti-tumor Therapy latest impact IF is 2.12. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.12 (2023) and 2.12 (2023), respectively, in the last 1 year. Moreover, its average IS is 2.12 in the previous 1 year.
The Exploration of Targeted Anti-tumor Therapy has an SJR (SCImago Journal Rank) of 0.692, according to the latest data. It is computed in the year 2024. In the past 1 years, this journal has recorded a range of SJR, with the highest being 0.692 in 2023 and the lowest being 0.692 in 2023. Furthermore, the average SJR of the Exploration of Targeted Anti-tumor Therapy over the previous 1-year period stands at 2.12.
The latest h-index of the Exploration of Targeted Anti-tumor Therapy is 10.
The Exploration of Targeted Anti-tumor Therapy is published by the Open Exploration Publishing Inc, with its country of publication being the China.
The Exploration of Targeted Anti-tumor Therapy is currently ranked 7575 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 1 year, this journal has experienced varying rankings, reaching its highest position of 7575 in 2023 and its lowest position of 7575 in 2023.
The standard ISO4 abbreviation for the Exploration of Targeted Anti-tumor Therapy is Explor. Target. Anti-tumor Ther..
Exploration of Targeted Anti-tumor Therapy is classified as a journal that the Open Exploration Publishing Inc publishes.
The Exploration of Targeted Anti-tumor Therapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Exploration of Targeted Anti-tumor Therapy is assigned the following International Standard Serial Numbers (ISSN): 26923114.
The best quartile for the Exploration of Targeted Anti-tumor Therapy is Q2 (2023).
The Exploration of Targeted Anti-tumor Therapy coverage history can be summarized as follows: 2020-2023.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
Business: Theory and Practice | journal | 14643 | Vilnius Gediminas Technical University | 26 | 2.37 |
Journal of Field Archaeology | journal | 5619 | Maney Publishing | 45 | 1.64 |
Journal of Applied Business Research | journal | 25715 | CIBER Institute | 32 | 0.19 |
International Journal of Parallel, Emergent and Distributed Systems | journal | 16153 | Taylor and Francis Ltd. | 25 | 1.10 |
Socialism and Democracy | journal | 25103 | Taylor and Francis Ltd. | 18 | 0.12 |
Sex Education | journal | 7722 | Routledge | 45 | 2.66 |
Natural Solutions | trade journal | 28581 | Innovision Health Media | 1 | 0.00 |
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS | conference and proceedings | 678 | Association for Computing Machinery (ACM) | 106 | 7.58 |
Archives of the Balkan Medical Union | journal | 23592 | Balkan Medical Union | 12 | 0.21 |
Year | Impact Score (IS) |
---|---|
2024/2025 | Coming Soon |
2023 | 2.12 |